SJ

Sanjay Jala

Active Director Director DIN 10568093
DIN 10568093 First appointment Mar 2024 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Mar 2024
Shareholding value Locked Premium profile

About Sanjay Jala

Sanjay Jala has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Prelims Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10568093
Primary Designation Director
First Appointment 28 Mar 2024
Oldest Company Age 2 yrs

Current companies

Company Designation Appointment Founded Status
Prelims Pharma Private Limited U21000HR2024PTC120218
Director 28 Mar 2024 2024 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Prelims Pharma Private Limited
Premium access

Shareholding and investment profile for Sanjay Jala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Jala

Sanjay Jala has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Prelims Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Sanjay Jala is associated with 1 company as Director.

Sanjay Jala has expertise in General Business.

Sanjay Jala has 2 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available